737: Is a Quinolone Really Superior to a Macrolide for Legionella Pneumonia?
736: Empiric vs Diagnostic Approach to Antifungal Therapy for High-Risk Neutropenic Patients with Persistent Fever
735: Will restrictive fluid strategies make it into standard sepsis care?
734: Does the manner of tranexamic acid application change the effectiveness for epistaxis?
733: How a pharmacist can ensure the best possible outcomes for status epilepticus
732: Is the vancomycin – piperacillin-tazobactam AKI interaction just pseudotoxicity?
731: Company sponsored indrect comparison concludes the company’s product is better for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage
730: Does the bispectral index correlate well to commonly used sedation scales?
729: What Works Best for Toxin-Related Status Epilepticus?
728: Acetazolamide as a respiratory stimulant
727: Dealing with and preventing negative interactions with other professionals
- « Previous Page
- 1
- …
- 30
- 31
- 32
- 33
- 34
- …
- 93
- Next Page »